[{"address1": "225 Franklin Street", "address2": "26th Floor", "city": "Boston", "state": "MA", "zip": "02110", "country": "United States", "phone": "857 246 8998", "website": "https://www.pieris.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Pieris Pharmaceuticals, Inc., a biotechnology company, discovers and develops biotechnological applications. The company focuses on the development of its 4-1BB bispecifics immuno-oncology (IO) programs. Its clinical pipeline consists of IO bispecifics, including S095012 (PRS-344), a bispecific Mabcalin compound targeting PD-L1 and 4-1BB in partnership with Les Laboratoires Servier and Institut de Recherches Internationales Servier; SGN-BB228 (PRS-346), a CD228 x 4-1BB bispecific antibody-Anticalin compound targeting CD228 and 4-1BB in partnership with Pfizer Inc.; and BOS-342 (PRS-342), a GPC3 x 4-1BB bispecific Mabcalin compound targeting GPC3 and 4-1BB in partnership with Boston Pharmaceuticals, which are in phase 1 studies. The company was founded in 2001 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 46, "companyOfficers": [{"maxAge": 1, "name": "Mr. Stephen S. Yoder J.D.", "age": 47, "title": "CEO, President & Director", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 744134, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas  Bures", "age": 48, "title": "Senior VP, CFO & Treasurer", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 487501, "exercisedValue": 0, "unexercisedValue": 5120349}, {"maxAge": 1, "name": "Dr. Shane  Olwill Ph.D.", "age": 47, "title": "Senior VP & Chief Development Officer", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 463909, "exercisedValue": 0, "unexercisedValue": 8086283}, {"maxAge": 1, "name": "Maria  Kelman", "title": "Executive Director of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Prompong  Chaikul", "age": 36, "title": "Chief Supply Chain Officer", "yearBorn": 1987, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Florian  Witte Ph.D.", "title": "VP and Head of Alliance Management & Early Project Leadership", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 16.82, "open": 17.29, "dayLow": 17.07, "dayHigh": 18.5, "regularMarketPreviousClose": 16.82, "regularMarketOpen": 17.29, "regularMarketDayLow": 17.07, "regularMarketDayHigh": 18.5, "beta": 0.68, "forwardPE": -90.75, "volume": 16594, "regularMarketVolume": 16594, "averageVolume": 134554, "averageVolume10days": 89680, "averageDailyVolume10Day": 89680, "bid": 17.72, "ask": 18.76, "bidSize": 100, "askSize": 100, "marketCap": 23962356, "fiftyTwoWeekLow": 6.2, "fiftyTwoWeekHigh": 41.76, "priceToSalesTrailing12Months": 1.1480622, "fiftyDayAverage": 11.8685, "twoHundredDayAverage": 13.316785, "currency": "USD", "enterpriseValue": 4231356, "profitMargins": -1.14115, "floatShares": 716996, "sharesOutstanding": 1320240, "sharesShort": 101670, "sharesShortPriorMonth": 17852, "sharesShortPreviousMonthDate": 1719532800, "dateShortInterest": 1722384000, "sharesPercentSharesOut": 0.077, "heldPercentInsiders": 0.06969, "heldPercentInstitutions": 0.47714, "shortRatio": 0.32, "shortPercentOfFloat": 0.0958, "bookValue": 14.168, "priceToBook": 1.2810558, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -23818000, "trailingEps": -19.21, "forwardEps": -0.2, "lastSplitFactor": "2:1", "lastSplitDate": 1417996800, "enterpriseToRevenue": 0.203, "enterpriseToEbitda": -0.373, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "PIRS", "underlyingSymbol": "PIRS", "shortName": "Pieris Pharmaceuticals, Inc.", "longName": "Pieris Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 1420209000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "8fe43177-b19a-3ae9-9f2a-563a55a71915", "gmtOffSetMilliseconds": -14400000, "currentPrice": 18.15, "recommendationMean": 3.0, "recommendationKey": "hold", "totalCash": 19731000, "totalCashPerShare": 14.945, "ebitda": -11335000, "quickRatio": 3.845, "currentRatio": 3.948, "totalRevenue": 20872000, "revenuePerShare": 16.66, "returnOnAssets": -0.13184, "returnOnEquity": -0.80461997, "freeCashflow": -25493500, "operatingCashflow": -37868000, "grossMargins": 0.23256001, "ebitdaMargins": -0.54307, "operatingMargins": -0.56899, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-08-22"}]